Exchange Traded Concepts’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Exchange Traded Concepts’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,143	Closed	-$285K	–	1323
2024 Q1	$285K	Buy	8,143 +1,438	+21%	+$52.4K	0.01%	823
2023 Q4	$255K	Buy	6,705 +1,700	+34%	+$36.4K	0.01%	769
2023 Q3	$91.8K	Sell	5,005 -160	-3%	-$3.35K	﹤0.01%	931
2023 Q2	$134K	Buy	+5,165	New	+$121K	﹤0.01%	877

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Exchange Traded Concepts's INBX Position: Q2 2024 in Review

Exchange Traded Concepts sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 8,143 shares — an estimated $285K sold.

Exchange Traded Concepts first reported a position in INBX in Q2 2023 and held it in 4 quarters. The position peaked at $285K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Exchange Traded Concepts reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Exchange Traded Concepts sold 8,143 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $285K.
Exchange Traded Concepts first reported a position in Inhibrx, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Exchange Traded Concepts's Inhibrx, Inc. Common Stock position peaked at $285K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Exchange Traded Concepts's 13F filing for Q2 2024, filed 13 Aug 2024.